The role of predictive vaginal biomarkers in women with cervical cerclage.
Publication/Presentation Date
7-1-2018
Abstract
Cervical cerclage is currently one of the primary methods of treatment for cervical insufficiency (CI). Identifying methods in order to selectively apply cerclage may allow us to further limit unnecessary procedures. In this regard, a limited number of inflammatory and extracellular matrix biomarkers measurable non-invasively at the level of the cervix have been examined. In this review we summarize the current research on the use of cervical biomarkers in predicting cerclage failure and propose potential objectives for future research.
Volume
31
Issue
13
First Page
1792
Last Page
1797
ISSN
1476-4954
Published In/Presented At
Kanninen, T. T., Sisti, G., Di Tommaso, M., & Berghella, V. (2018). The role of predictive vaginal biomarkers in women with cervical cerclage. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 31(13), 1792–1797. https://doi.org/10.1080/14767058.2017.1326895
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
28475391
Department(s)
Administration and Leadership
Document Type
Article